Médecins Sans Frontières - TEASER EN_endTB climicl trial results

Unique Identifier Code / URN MSB178200

Date taken / Date Recorded 30/10/2023 12:00 AM

Country Georgia, India, Kazakhstan, Lesotho, Pakistan, Peru, South Africa

Usage Rights (MSF) External Media, MSF Fundraising, MSF Publications, Social Media

Formal Consent Copy available yes

Editor's rating ★★★ (F)

Video format h264 (High) (avc1 / 0x31637661)

Duration 2m8s

Maximum Size 1920px × 1080px 256.86 MB

Additional Information / Shotlist Lorenzo Guglielmetti
endTB trial Co-Principal Investigator

More than six years ago, the endTB trial started to transform MDR-TB treatments, which were long, ineffective and had terrible side effects. The study was performed to identify radically shorter, more tolerable, and injection-free treatments for MDR-TB.

Carole D. Mitnick
endTB trial Co-Principal Investigator

The Unitaid funded endTB trial is a phase III randomised trial that recruited and followed 754 volunteers with MDR-TB or RR-TB in seven countries around the world. We are very excited to present the first endTB trial results at the Union World Conference, in Paris, this year and showcase evidence for better MDR-TB treatment for all.

Dr Nana Kiria
endTB trial Principal Investigator in Georgia

The endTB study expanded the border for clinical trial projects in the field of tuberculosis.
Dr Samiran Panda
endTB trial Principal Investigator in India

The endTB trial is offering a much needed shot in the arm of the national programmes and the policies by generating evidence of immense good quality.

Dr Amanzhan Abubakirov
endTB trial Principal Investigator in Kazakhstan

We were able to achieve successful results, treat every patient.
Dr Dante Elmo Vargas Vásquez
endTB trial Principal Investigator in Peru

endTB has been an excellent opportunity to demonstrate the efficacy and safety of shortened oral regimens in the fight against tuberculosis.
Dr Naseem Salahuddin
endTB trial Principal Investigator in Pakistan

This trial is a game-changer.

Dr Lawrence Oyewusi
endTB trial Principal Investigator in Lesotho

We actually look forward to seeing the improvement that will come to the lives of our patients by using the endTB clinical trial regimen.

Join us in November at The Union World Conference, in Paris, where we will publicly share the endTB trial results for the very first time.
We will present the results in a Symposium and a Community Connect session.

We look forward to sharing these results, which will benefit the global TB community.

Symposium:
Innovation to guide practice in MDR/RR-TB treatment: efficacy and safety results of the endTB trial
10:15-11:45 on November 15
At the Union World Conference

Community connect session:
Researchers sharing with communities: Results from the endTB trial.
18:00-18:45 on November 17
At the Union World Conference